Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
Holding ORMP?
Track your performance easily

Oramed Pharm (ORMP) Financial Statements

508 Followers

Oramed Pharm Financial Overview

Oramed Pharm's market cap is currently ―. The company's EPS TTM is $0.509; its P/E ratio is 4.62; Oramed Pharm is scheduled to report earnings on July 10, 2024, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue----$ 674.00K
Gross Profit----$ 674.00K
EBIT$ 11.10M$ 2.13M$ 14.51M$ -2.46M$ -3.79M
EBITDA$ 11.15M$ 2.18M$ 14.56M-$ -3.74M
Net Income Common Stockholders$ 9.21M$ 1.54M$ 13.55M$ -3.22M$ -1.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 150.96M$ 96.31M$ 66.77M$ 5.47M$ 7.71M
Total Assets$ 184.22M$ 203.65M$ 220.55M$ 230.89M$ 156.31M
Total Debt$ 486.00K$ 32.56M$ 51.95M$ 76.00M$ 727.00K
Net Debt$ -150.47M$ -63.75M$ -14.82M$ 70.53M$ -6.98M
Total Liabilities$ 8.07M$ 37.93M$ 57.66M$ 82.66M$ 5.66M
Stockholders Equity$ 177.06M$ 166.64M$ 163.82M$ 149.13M$ 151.55M
Cash Flow-
Free Cash Flow$ 2.08M$ -1.48M$ -1.42M-$ -2.65M
Operating Cash Flow$ 2.08M$ -1.48M$ -1.42M$ -694.00K$ -2.63M
Investing Cash Flow$ 94.66M$ 30.00M$ 30.00M$ -75.12M$ -14.71M
Financing Cash Flow$ -30.55M$ -19.00M$ -25.00M$ 74.55M-
Currency in USD

Oramed Pharm Earnings and Revenue History

Oramed Pharm Debt to Assets

Oramed Pharm Cash Flow

Oramed Pharm Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis